A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of V117 Formulation C in Healthy Adults

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/001/1/00

Funding

  • Merck Sharp and Cohme Corporation ( Award # ): $12,750.00